Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CORCEPT THERAPEUTICS INC | Chief Executive Officer, Director | Common Stock | 2.48M | $96M | $38.67 | Jul 31, 2024 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 |
CORCEPT THERAPEUTICS INC | Chief Executive Officer, Director | Common Stock | 539K | $20.9M | $38.67 | Jul 31, 2024 | Direct |
CORCEPT THERAPEUTICS INC | Chief Executive Officer, Director | Stock option (right to buy) | 0 | Jul 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CORT | CORCEPT THERAPEUTICS INC | Jul 31, 2024 | 3 | -$8.56M | 4 | Aug 2, 2024 | Chief Executive Officer, Director |
CORT | CORCEPT THERAPEUTICS INC | Feb 9, 2024 | 1 | $0 | 4 | Feb 13, 2024 | Chief Executive Officer, Director |
CORT | CORCEPT THERAPEUTICS INC | Jul 6, 2022 | 5 | -$19M | 4 | Jul 8, 2022 | Chief Executive Officer |
CORT | CORCEPT THERAPEUTICS INC | Feb 13, 2022 | 1 | $0 | 4 | Feb 15, 2023 | Chief Executive Officer, Director |
CORT | CORCEPT THERAPEUTICS INC | Feb 2, 2022 | 1 | $0 | 4 | Feb 11, 2022 | Chief Executive Officer, Director |